Evaluation of Hemostasis in Bleeding and Thrombotic Disorders



Status:Completed
Conditions:Cardiology, Hematology, Hematology
Therapuetic Areas:Cardiology / Vascular Diseases, Hematology
Healthy:No
Age Range:Any
Updated:4/2/2016
Start Date:October 2002
End Date:January 2016
Contact:Madeline Cantini, BSN
Email:madeline.cantini@uth.tmc.edu
Phone:713-500-8377

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders Using the Roteg Analyzer and the Thrombin Generation Assay

The objective of this study will be to assess the coagulation system in-vitro in a variety
of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation
assay.

This is an exploratory study involving blood coagulation assays in a select group of
individuals. The ROTEG is a newly developed coagulation analyzer which allows the continuous
assessment of whole blood coagulation from the formation of the first fibrin fibers and
activated platelets, to the formation of a three-dimensional whole blood clot until the
eventual dissolution of the clot. This device will not be used as a diagnostic or procedure
tool. No recommendations regarding interpretation of the results or implications for future
treatment will be provided.

Inclusion Criteria:

- Congenital or Acquired Bleeding Disorder Congenital or Acquired Thrombotic Disorder

Exclusion Criteria:

- Poor venous access
We found this trial at
1
site
The Univerisity of Texas Health Science Center at Houston
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials